Cargando…
Effects of Sprifermin, IGF1, IGF2, BMP7, or CNP on Bovine Chondrocytes in Monolayer and 3D Culture
One possible approach to treat osteoarthritis (OA) is to counteract cartilage degeneration with anabolic compounds that stimulate chondrocyte proliferation and/or extracellular matrix (ECM) production. Several molecules including sprifermin (recombinant human fibroblast growth factor [FGF18]), insul...
Autores principales: | Müller, Sylvia, Lindemann, Sven, Gigout, Anne |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7065224/ https://www.ncbi.nlm.nih.gov/pubmed/31608492 http://dx.doi.org/10.1002/jor.24491 |
Ejemplares similares
-
Sprifermin (rhFGF18) modulates extracellular matrix turnover in cartilage explants ex vivo
por: Reker, Ditte, et al.
Publicado: (2017) -
Increasing the Medium Osmolarity Reduces the Inflammatory Status of Human OA Chondrocytes and Increases Their Responsiveness to GDF-5
por: Mang, Tanja, et al.
Publicado: (2020) -
The GDF‐5 mutant M1673 exerts robust anabolic and anti‐catabolic effects in chondrocytes
por: Mang, Tanja, et al.
Publicado: (2020) -
IGF2 and IGF1R identified as novel tip cell genes in primary microvascular endothelial cell monolayers
por: Dallinga, Marchien G., et al.
Publicado: (2018) -
Positive impact of IGF-1-coupled nanoparticles on the differentiation potential of human chondrocytes cultured on collagen scaffolds
por: Pasold, Juliane, et al.
Publicado: (2015)